Pharma
FDA Approves First-Ever Therapies for Niemann-Pick Disease Type C
In a significant breakthrough, the FDA has approved two new drugs for the treatment of Niemann-Pick Disease Type C (NPC), a rare and debilitating genetic
In a significant breakthrough, the FDA has approved two new drugs for the treatment of Niemann-Pick Disease Type C (NPC), a rare and debilitating genetic
Resolution Therapeutics has secured $85 million in new funding to continue developing its macrophage-based therapies for liver diseases. The company is leveraging the natural regenerative
In an exciting new development, Booster Therapeutics has entered the biotech space with a $15 million seed funding round. The company, which officially launched on
Cambridge-based biotech company Shift Bioscience has raised $16 million in seed funding to drive forward its cellular reprogramming research aimed at combating age-related diseases. The
The healthcare landscape is evolving rapidly, driven by groundbreaking advancements in biotechnology, medical technology, and pharmaceuticals. As investors and industry observers look ahead to 2025,
Biotechnology is advancing rapidly, driving innovation across healthcare, agriculture, food, and manufacturing. At the forefront of these advancements are gene editing technologies like CRISPR/Cas9, which
Personalized medicine, also known as precision medicine, is transforming the landscape of cancer treatment by tailoring therapies to each patient’s unique genetic makeup. This approach
The integration of artificial intelligence (AI) and machine learning (ML) into the medtech industry is accelerating the development of smart, data-driven healthcare devices. These technologies
The medical technology (medtech) industry is one of the most critical sectors in healthcare, driving innovation in diagnostics, treatment, and patient care. The following are
As we move through 2024, the landscape of medical technology and pharmaceutical innovation is being shaped by several high-impact clinical trials. These trials are poised